Recommended content

‘No reason’ for DEA to delay marijuana rescheduling, FDA chief says

There’s “no reason” for the U.S. Drug Enforcement Administration to delay its long-awaited decision on moving marijuana from Schedule 1 to Schedule 3 of the Controlled Substances Act, the head of the Food and Drug Administration told a House committee.

However,  FDA Commissioner Robert Califf seemed to hint Thursday that the DEA could treat adult-use marijuana – now legal in 25 statesdifferently than cannabis used for medicinal purposes.


Such a “bifurcation,” if applied to rescheduling, could have a profound impact on the U.S. marijuana industry, analysts observed Friday.

Tax relief for MMJ, not adult use?

It could mean medical marijuana businesses would enjoy tax relief that adult-use operators wouldn’t.

Califf’s comments came as part of a much lengthier and broader hearing

Read full article on Marijuana Business Daily

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Business Daily

More news